NCT02897778 2022-04-28Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid TumorsSyndax PharmaceuticalsPhase 1 Completed30 enrolled
NCT02909452 2022-01-25Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsSyndax PharmaceuticalsPhase 1 Completed30 enrolled
NCT00923520 2018-12-05A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed60 enrolled